ArticleDrug and alcohol dependence2023
Depressive symptoms and vaping: The mediating effect of outcome expectancies among young adults.
Article in Drug and alcohol dependence, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Tobacco-Use Susceptibility and Ever-Use Categories in Relation to Depressive Symptoms Among Undergraduates at a Chinese University: A Cross-Sectional Study.Healthcare (Basel, Switzerland) · 2026Article
- Mental health matters? An examination of how anxiety and depression influence the alcohol-e-cigarette use relationship.Addictive behaviors · 2026Article
- Virtual Reality for the Prevention and Cessation of Nicotine Vaping in Youths: Protocol for a Randomized Controlled Trial.JMIR research protocols · 2025Article
- Effects of Very Low Nicotine Content Cigarettes and Nicotine Vaping Device Characteristics on Choices to Smoke, Vape, or Abstain in Early Young Adults.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025Article
- Peers and Young Adult Electronic Nicotine Delivery Use: The Mediating Role of Vaping Attitudes/Beliefs.Substance use & misuse · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
objectiveThe purpose of the present study was to determine if positive affect reinforcement and social enhancement outcome expectancies mediate the longitudinal association between depressive symptoms and frequency of electronic nicotine delivery systems (ENDS) use one year later among young adults.
methodParticipants were 1567 young adults participating in the first three waves of the Marketing and Promotions Across Colleges in Texas project. At Wave 1 participants were 18-25 years old (M = 20.27; SD = 1.86), 61.46% female; 36.25% non-Hispanic white, 33.95% Hispanic/Latino, 14.10% Asian, 7.72% African American/Black, 7.98% two or more races/ethnicities or another race/ethnicity. The independent variable, depressive symptoms, was assessed with the CES-D-10 at Wave 1. The mediating variables, positive affect reinforcement and social enhancement ENDS outcome expectancies were assessed using items adapted from the Youth Tobacco Survey at Wave 2 six months later. The outcome variable was frequency of past 30-day ENDS use at Wave 3, one year after Wave 1. A mediation model was used to test the study hypothesis.
resultsPositive affect reinforcement ENDS outcome expectancies (b = 0.013, SE = 0.006, Bootstrap 95%CI: [0.003, 0.025]), but not social enhancement expectancies (b = -0.004, SE = 0.003, Bootstrap 95%CI: [-0.010, 0.0003]), mediated the positive association between elevated depressive symptoms and frequency of ENDS use one year later.
conclusionResults indicate young adults experiencing elevated depressive symptoms may use ENDS at a greater frequency than their peers because they believe ENDS use will alleviate stress, increase relaxation and/or concentration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.